We are pleased to announce the results of our joint efforts with Americares - the first deliveries of expensive antibiotics, Tigecycline and Piperacillin/Tazobactam, have reached hospitals in Kyiv, Lviv, Dnipro, Zaporizhzhia, and Vinnytsia.
Since the onset of the full-scale war in Ukraine, the issue of antimicrobial resistance has intensified due to the increased number of casualties. Some of the wounded and military personnel are experiencing infectious complications caused by pathogens resistant to most antibiotics in over 75%, and in some cases – up to 100%. In such situations, antibiotics from the "reserve" group, such as Tigecycline, are used. Piperacillin/Tazobactam, on the other hand, is an "observational" antibiotic prescribed for the treatment of polymicrobial infections, including those suspected of gram-positive and gram-negative aerobic and/or anaerobic microorganisms.
We would like to emphasize that reserve antibiotics should be used exclusively to overcome pathogens that are resistant to many other drugs. These are medications designed as a last resort to save lives and health when nothing else is effective against the infection. Their use outside the healthcare facility is unacceptable.